Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.32 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.32 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.31 |
| ▸ | EED | O75530 | 1/20 | 0.31 |
| ▸ | RBBP4 | Q09028 | 1/20 | 0.31 |
| ▸ | SUZ12 | Q15022 | 1/20 | 0.31 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.31 |
| ▸ | AEBP2 | Q6ZN18 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6748055 | 0.79 | CYP2D6 (0.39) | BRD4HSD11B2SLC6A2SLC6A4CYP2D6 | |
| SCHEMBL6748053 | 0.79 | CYP2D6 (0.39) | BRD4HSD11B2SLC6A2SLC6A4CYP2D6 | |
| SCHEMBL6750153 | 0.76 | KDM4E (0.37) | BRD4HSD11B2SPHK1 | |
| SCHEMBL6750156 | 0.76 | KDM4E (0.37) | BRD4HSD11B2SPHK1 | |
| SCHEMBL6752543 | 0.76 | CYP2D6 (0.35) | SLC6A2SLC6A4CYP2D6NOS2 | |
| SCHEMBL6186125 | 0.74 | CYP2D6 (0.42) | BRD4HSD11B2CYP2D6SPHK1 | |
| SCHEMBL6186128 | 0.74 | CYP2D6 (0.42) | BRD4HSD11B2CYP2D6SPHK1 | |
| SCHEMBL6750975 | 0.74 | CYP2D6 (0.52) | SLC6A2SLC6A4CYP2D6NOS2SMN1; SMN2 | |
| SCHEMBL6842377 | 0.74 | CYP2D6 (0.52) | SLC6A2SLC6A4CYP2D6NOS2SMN1; SMN2 | |
| SCHEMBL7269484 | 0.69 | SPHK1 (0.47) | BRD4HSD11B2NR1H2SPHK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040242871-A1 | Novel arylheteroalkylamine derivatives | ASTRAZENECA AB (SE) | 2004-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242871-A1 | Novel arylheteroalkylamine derivatives | CYP1A1, NOS3, NOS1 | BRD4 3935/4885HSD11B2 894/4885NR1H2 119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.